Self-Injurious BehaviorNCT06739616
Expanding Interventions for Automatically Maintained SIB
A study testing AUTOSIB across time and AUTOSIB diminished reinforcement in people with Self-Injurious Behavior and Problem Behavior, run by University of Georgia at 1 site in United States.
Trial summary
The goal of this clinical trial is to demonstrate feasibility of procedures and compare the outcomes of intervention arrangements to reduce sensory based self-injurious behavior exhibited by individuals with intellectual and developmental disabilities. Read more about this study
- Who is it for?
- Ages 2 years and older
- Conditions the study is for
- Self-Injurious Behavior, Problem Behavior, Intellectual Disability
- What is being tested?
- AUTOSIB across time and AUTOSIB diminished reinforcement
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 7 participants
- Where
- 1 siteUnited States
- Study dates
- 18 Apr 2023to 31 Aug 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- 2 years and older
- Diagnosis of intellectual and/or developmental disability
- Referred for assessment and treatment of self-injurious behavior
- Behavior maintained by automatic reinforcement function
Who cannot join
- Behavior maintained by a social reinforcement (e.g., attention, escape) function
Trial locations and contacts
1 site in 1 country.
About this study
The goal of this clinical trial is to demonstrate feasibility of procedures and compare the outcomes of intervention arrangements to reduce sensory based self-injurious behavior exhibited by individuals with intellectual and developmental disabilities. The main question[s] it aims to answer are:
(1) Demonstrate ability to meet enrollment requirements. (2) Evaluate acceptability and feasibility of participation relative to observation length and study duration. (3) Track and compare participant progress across interventions. (4) Demonstrate acceptable procedural fidelity and interobserver agreement. And (5) conduct post hoc evaluation of clinical presentation and intervention match.
Participants will [describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items]. If there is a comparison group: Researchers will compare [insert groups] to see if [insert effects].
Read the detailed description
Individuals with intellectual and developmental disabilities (IDD) such as autism spectrum disorder (ASD) often engage in restricted and repetitive behaviors (RRBs). In fact, RRB is a diagnostic hallmark of ASD. For some, these behaviors cause, or have the potential to cause, injury to the individual exhibiting the behavior. Research has demonstrated that operant contingencies, and particularly automatic reinforcement, play a role in the maintenance of such behavior. Automatic reinforcement means that the behavior directly produces the outcomes that maintain it, without the requirement of a social interaction. For example, scratching a mosquito bite is a behavior maintained by the automatic negative reinforcer of attenuating an aversive sensation, while eating a piece of candy is maintained by the automatic positive reinforcer of sweet taste. Epidemiologic studies indicate that between 15% and 30% of cases of self-injurious behavior (SIB) are maintained by automatic reinforcement. This type of SIB has been noted to be particularly difficult to treat. However, a relatively recent review of the literature reported that reinforcement-based interventions such as non-contingent reinforcement (NCR), which involves response-independent reinforcer delivery, and combinations of differential reinforcement (DR) with NCR can be highly effective interventions for this type of behavior. Further, others provided preliminary evidence that response patterns during pre-treatment assessments could be used to identify cases for whom NCR would be effective, versus cases for which DR would be effective.
While NCR and DR have demonstrated efficacy, the literature lacks critical evaluation of successful application of these interventions to reduce automatically maintained SIB along at least two dimensions. 1) No studies demonstrate longevity of treatment effects. In most studies, demonstrations of efficacy have occurred during brief (5-15 min) sessions conducted one to several times per day. Interventions may be successful during those brief time periods, but it remains unknown whether intervention effects would continue if implemented over longer periods (e.g., 60 min). 2) Across existing studies, dense reinforcement schedules are used and little is known about whether intervention effects would continue as reinforcement schedules are thinned to levels practical in natural settings. The investigators propose a project to address these gaps in the literature. Our proposed research plan builds off prior research investigating differential effects of matched (stimuli that produce effect similar to the presumed reinforcing effect of SIB) and unmatched (produce an effect dissimilar to that presumed to result from SIB) stimuli used as reinforcers in NCR and other DR-based interventions. The literature on intervention for automatically maintained SIB demonstrates that both matched and unmatched stimuli may reduce SIB in NCR and DR-based interventions. The investigators propose to evaluate relative effects of matched and unmatched stimuli (a) over time and (b) during schedule thinning. Because of the nature and importance of the topic, questions related to participant recruitment, extended session times planned for treatment evaluations, and measurement of procedural fidelity need to be addressed in a preliminary investigation. The current proposal will thus have the following aims.
Specific Aim 1: Demonstrate ability to meet enrollment requirements. The larger project (R01) proposed an enrollment of 50 participants over 5 years, with 40 participants anticipated to complete the studies. Enrollment target for this R56 will be seven to 10 participants evenly split across the two proposed studies. The investigators will randomize the first participant and then alternate assignment for subsequent participants. The investigators anticipate five to seven participants completing. Based on published data regarding reinforcement-based interventions for SIB maintained by automatic reinforcement, the investigators anticipate two-thirds of the participants will receive NCR and one-third will receive DRO. To assess feasibility of the defined recruitment targets, the investigators will collect data on the following: number of responses to recruitment efforts including, when possible, the proportion of possible participants who responded to recruitment efforts; proportion of potential participants who did not continue in the consent process following screen and the reason (e.g., declined further participation, screened out due to inclusion criteria); and proportion of participants and potential participants who exited the study at any point following initial screen as well as the reason (e.g., decided to withdraw).
Specific Aim 2: Evaluate acceptability and feasibility of participation relative to observation length and study duration. The larger study includes observation periods with intervention implemented for up to 180 min (3 hours) and an anticipated study duration of 24 weeks. To determine parent/caregiver acceptability of these longer session appointments, social validity will be measured over the course of the project using modified versions of the Parent Evaluation Inventory (PEI) and the Therapist Evaluation Inventory (TEI). Each measure includes 19 items and assesses the extent to which caregivers view interventions positively. The investigators will modify the instruments so that (a) they are appropriate for caregivers who are not parents (for May Institute participants whose caregivers will be teachers and direct care staff), and (b) assess the acceptability of procedural features (e.g., pre-intervention assessments, session duration) in addition to acceptability of the intervention. The PEI and TEI have been widely used in behavioral intervention studies. Investigators will administer the measures after completion of (1) pre-intervention assessment (preference assessment, functional analysis, COAB), (2) efficacy evaluation, and (3) intervention tests. As a further assessment of social validity, attendance and dropouts will be monitored and the investigators will continuously monitor participant assent to determine whether participants are more likely to withdrawal assent as observation periods increase. Data related to study duration for participants completing the study protocols will be used to more accurately propose individual participation timelines for the subsequent R01 application.
Specific Aim 3: Track participant progression. Participant progress through the study protocols will be tracked to determine if the individual timeline proposed is adequate, or requires adjustment. In particular, the investigators will evaluate whether the stated phase change criteria (currently based on IES SCD criteria) need to be adjusted to allow for either more efficient progress through the study phases or more convincing demonstration of experimental control.
Specific Aim 4: Demonstrate acceptable procedural fidelity with intervention implementation and Interobserver agreement (IOA).
Fidelity. The study will be conducted across two demonstration sites (May Institute and the University of Georgia). Thus, uniformity of implementation could vary. During the R56 period, the proposed training program will be implemented, and data will be collected on procedural fidelity and compared across sites.
Specifically, the investigators will directly measure procedural fidelity across all conditions to ensure the integrity of the procedures. Conforming with generally accepted practices in SCD, the investigators will use direct observation instruments reflective of the individual study protocols and evaluate for errors of omission and commission across at least 30% of all sessions, evenly distributed across study conditions and phases, for all participants and all implementers. These instruments typically consist of task analyses that specify what implementers should do (e.g., provide response-independent access to the reinforcer every 30 s), and what they should avoid (e.g., no vocal response from the therapist if SIB occurs). Investigators will then compute a measure of fidelity related (e.g., conditional probabilities of correct procedures and incorrect therapist behavior) to these two forms of errors relative to the planned steps and components for those conditions. Fidelity data will largely be collected in vivo, though recordings can be accessed if necessary (sometimes therapists and clients move out of frame of the camera so the investigators do not want to rely on video for fidelity data collection). To assist with procedural uniformity, May Institute will train implementers across sites and meet weekly with observers to review fidelity of implementation data and provide additional training. Adjustments to training procedures will be made or training boosters will be conducted if procedural fidelity drops below 90% for three consecutive implementations of any given procedure.
IOA: Mulitple data collectors will be responsible for in vivo data collection over the course of the study. To ensure that observation records reliably reflect what occurred during sessions, IOA will be tracked across all phases and conditions. Specifically, a second, naive, observer will collect data for IOA across all conditions using the same instrument as the primary data collector. Aligning with the generally accepted standards in SCD, these data will be gathered across at least 30% of sessions in each condition for each participant. The investigators will compare data between the observers to compute a measure of IOA. Data collectors will undergo a review of definitions and practice if IOA scores fall below 90% for three consecutive observations.
Specific Aim 5: Post hoc evaluation of subtype/intervention match. Following the conclusion of the study for each participant, the subtype of their SIB, the prescribed intervention, and the intervention outcome will be denoted. This process will allow for additional data sets related to subtype prevalence and subtype by intervention outcome to be collected. Individuals who exhibit SIB that fits Subtype 3 (i.e., SIB with self-restraint) will be reviewed on a case-by-case basis. If their self-restraint eliminates the occurrence of SIB, they will not be included in the study as SIB will not occur during the assessment phase.
- Conditions
- Self-Injurious Behavior, Problem Behavior, Intellectual Disability, Autism Spectrum Disorder, Restricted Behavior
- Being tested
- AUTOSIB across time, AUTOSIB diminished reinforcement
- Medical subject headings
- Self-Injurious Behavior, Problem Behavior, Intellectual Disability, Autism Spectrum Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AUTOSIB across timeBehavioural
Intervention will be in place across increasing time frames.
AUTOSIB diminished reinforcementBehavioural
Intervention will be in place with decreasing levels of reinforcement
| Study group | Role | What they receive |
|---|---|---|
| Study 1: Longevity | Experimental | Study 1: Longevity will evaluate the impact of matched and unmatched competing stimuli on reinforcement-based interventions as implementation durations are increased. Three conditions will be compared, using within-subjects single case designs: (a) baseline (no intervention), (b) intervention with competing stimuli matched to the hypothesized sensory consequences of SIB, and (c) intervention with competing stimuli unmatched to the hypothesized sensory consequences of SIB. Participants' specific intervention will be either noncontingent reinforcement (NCR) or differential reinforcement of other behavior (DRO), based on the outcomes of the pre-intervention assessments. During NCR, participants will receive access to competing stimuli on an ongoing and response-independent basis. During DRO, participants will receive access to competing stimuli contingent on the omission of SIB for a pre-determined length of time. Implementation will gradually increase up to a maximum of three hours. Receives: Behavioral: AUTOSIB across time |
| Study 2: Schedule Thinning | Experimental | Study 2: Schedule Thinning will evaluate the impact of matched and unmatched competing stimuli on reinforcement-based interventions as access to reinforcers decreases. Three conditions will be compared, using within-subjects single case designs: (a) baseline (no intervention), (b) intervention with competing stimuli matched to the hypothesized sensory consequences of SIB, and (c) intervention with competing stimuli unmatched to the hypothesized sensory consequences of SIB. Participants' specific intervention will be either noncontingent reinforcement (NCR) or differential reinforcement of other behavior (DRO), based on the outcomes of the pre-intervention assessments. During NCR, participants will receive access to competing stimuli on an ongoing and response-independent basis. During DRO, participants will receive access to competing stimuli contingent on the omission of SIB for a pre-determined length of time. Access to reinforcers will decrease across successful implementations. Receives: Behavioral: AUTOSIB diminished reinforcement |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rate of Self-Injurious Behavior exhibited by individual participants as measured by direct observation
Behavior that causes or has potential to cause injury to the participant
Measured: Change in level of SIB from pre-intervention to intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Dec 2024
- Study start18 Apr 2023
- Primary completion31 Aug 2024
- Study completion31 Aug 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Self-Injurious BehaviorStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Single case research design
- Masking
- None (open label)
- Enrolment
- 7 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Georgia
- Sponsor type
- University, hospital or other
- Collaborators
- May Institute
- Responsible party
- Principal investigator, Joel E. Ringdahl, University of Georgia
- Investigators
- Joel E Ringdahl, PhD, Principal investigator, University of Georgia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06739616
- Sponsor's protocol ID
- 00006603
- Status last verified
- Dec 2024
- First submitted
- 8 Feb 2023
- Last updated
- 27 Dec 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The investigators will upload data to NIMH's National Database for Autism Research (NDAR). This process begins within six months of the award by creating a list of all data expected to be collected in the project using the Data Expected feature in NDAR, completing the NIMH Data Archive Data Submission Agreement form, and providing all necessary materials for any structures not yet defined in the NDA Data Dictionary. Within three months of receiving this information, NDAR contacts the study team to refine the plan for uploading the data. Item-level data for individual subjects are entered into NDAR for all study measures. Researchers are expected to associate the data deposited in NDA with their publications/findings - both positive and negative - using the NDA Study feature so that other researchers can locate the data. NDAR also allows researchers to search for data by study name.
Study at a glance
From the registry record, last updated by the sponsor on 27 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Expanding Interventions for Automatically Maintained SIB
- ClinicalTrials.gov ID
- NCT06739616
- Acronym / sponsor ID
- 00006603
- Conditions
- Self-Injurious Behavior, Problem Behavior, Intellectual Disability, Autism Spectrum Disorder, Restricted Behavior
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 7 participants (actual)
- Lead sponsor
- University of GeorgiaUniversity, hospital or other
- Collaborators
- May Institute
- Study start
- 18 Apr 2023 (actual)
- Primary completion
- 31 Aug 2024 (actual)
- Study completion
- 31 Aug 2024 (actual)
- First posted
- 18 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to demonstrate feasibility of procedures and compare the outcomes of intervention arrangements to reduce sensory based self-injurious behavior exhibited by individuals with intellectual and developmental disabilities. The main question[s] it aims to answer are:
(1) Demonstrate ability to meet enrollment requirements. (2) Evaluate acceptability and feasibility of participation relative to observation length and study duration. (3) Track and compare participant progress across interventions. (4) Demonstrate acceptable procedural fidelity and interobserver agreement. And (5) conduct post hoc evaluation of clinical presentation and intervention match.
Participants will [describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items]. If there is a comparison group: Researchers will compare [insert groups] to see if [insert effects].
Detailed description
Individuals with intellectual and developmental disabilities (IDD) such as autism spectrum disorder (ASD) often engage in restricted and repetitive behaviors (RRBs). In fact, RRB is a diagnostic hallmark of ASD. For some, these behaviors cause, or have the potential to cause, injury to the individual exhibiting the behavior. Research has demonstrated that operant contingencies, and particularly automatic reinforcement, play a role in the maintenance of such behavior. Automatic reinforcement means that the behavior directly produces the outcomes that maintain it, without the requirement of a social interaction. For example, scratching a mosquito bite is a behavior maintained by the automatic negative reinforcer of attenuating an aversive sensation, while eating a piece of candy is maintained by the automatic positive reinforcer of sweet taste. Epidemiologic studies indicate that between 15% and 30% of cases of self-injurious behavior (SIB) are maintained by automatic reinforcement. This type of SIB has been noted to be particularly difficult to treat. However, a relatively recent review of the literature reported that reinforcement-based interventions such as non-contingent reinforcement (NCR), which involves response-independent reinforcer delivery, and combinations of differential reinforcement (DR) with NCR can be highly effective interventions for this type of behavior. Further, others provided preliminary evidence that response patterns during pre-treatment assessments could be used to identify cases for whom NCR would be effective, versus cases for which DR would be effective.
While NCR and DR have demonstrated efficacy, the literature lacks critical evaluation of successful application of these interventions to reduce automatically maintained SIB along at least two dimensions. 1) No studies demonstrate longevity of treatment effects. In most studies, demonstrations of efficacy have occurred during brief (5-15 min) sessions conducted one to several times per day. Interventions may be successful during those brief time periods, but it remains unknown whether intervention effects would continue if implemented over longer periods (e.g., 60 min). 2) Across existing studies, dense reinforcement schedules are used and little is known about whether intervention effects would continue as reinforcement schedules are thinned to levels practical in natural settings. The investigators propose a project to address these gaps in the literature. Our proposed research plan builds off prior research investigating differential effects of matched (stimuli that produce effect similar to the presumed reinforcing effect of SIB) and unmatched (produce an effect dissimilar to that presumed to result from SIB) stimuli used as reinforcers in NCR and other DR-based interventions. The literature on intervention for automatically maintained SIB demonstrates that both matched and unmatched stimuli may reduce SIB in NCR and DR-based interventions. The investigators propose to evaluate relative effects of matched and unmatched stimuli (a) over time and (b) during schedule thinning. Because of the nature and importance of the topic, questions related to participant recruitment, extended session times planned for treatment evaluations, and measurement of procedural fidelity need to be addressed in a preliminary investigation. The current proposal will thus have the following aims.
Specific Aim 1: Demonstrate ability to meet enrollment requirements. The larger project (R01) proposed an enrollment of 50 participants over 5 years, with 40 participants anticipated to complete the studies. Enrollment target for this R56 will be seven to 10 participants evenly split across the two proposed studies. The investigators will randomize the first participant and then alternate assignment for subsequent participants. The investigators anticipate five to seven participants completing. Based on published data regarding reinforcement-based interventions for SIB maintained by automatic reinforcement, the investigators anticipate two-thirds of the participants will receive NCR and one-third will receive DRO. To assess feasibility of the defined recruitment targets, the investigators will collect data on the following: number of responses to recruitment efforts including, when possible, the proportion of possible participants who responded to recruitment efforts; proportion of potential participants who did not continue in the consent process following screen and the reason (e.g., declined further participation, screened out due to inclusion criteria); and proportion of participants and potential participants who exited the study at any point following initial screen as well as the reason (e.g., decided to withdraw).
Specific Aim 2: Evaluate acceptability and feasibility of participation relative to observation length and study duration. The larger study includes observation periods with intervention implemented for up to 180 min (3 hours) and an anticipated study duration of 24 weeks. To determine parent/caregiver acceptability of these longer session appointments, social validity will be measured over the course of the project using modified versions of the Parent Evaluation Inventory (PEI) and the Therapist Evaluation Inventory (TEI). Each measure includes 19 items and assesses the extent to which caregivers view interventions positively. The investigators will modify the instruments so that (a) they are appropriate for caregivers who are not parents (for May Institute participants whose caregivers will be teachers and direct care staff), and (b) assess the acceptability of procedural features (e.g., pre-intervention assessments, session duration) in addition to acceptability of the intervention. The PEI and TEI have been widely used in behavioral intervention studies. Investigators will administer the measures after completion of (1) pre-intervention assessment (preference assessment, functional analysis, COAB), (2) efficacy evaluation, and (3) intervention tests. As a further assessment of social validity, attendance and dropouts will be monitored and the investigators will continuously monitor participant assent to determine whether participants are more likely to withdrawal assent as observation periods increase. Data related to study duration for participants completing the study protocols will be used to more accurately propose individual participation timelines for the subsequent R01 application.
Specific Aim 3: Track participant progression. Participant progress through the study protocols will be tracked to determine if the individual timeline proposed is adequate, or requires adjustment. In particular, the investigators will evaluate whether the stated phase change criteria (currently based on IES SCD criteria) need to be adjusted to allow for either more efficient progress through the study phases or more convincing demonstration of experimental control.
Specific Aim 4: Demonstrate acceptable procedural fidelity with intervention implementation and Interobserver agreement (IOA).
Fidelity. The study will be conducted across two demonstration sites (May Institute and the University of Georgia). Thus, uniformity of implementation could vary. During the R56 period, the proposed training program will be implemented, and data will be collected on procedural fidelity and compared across sites.
Specifically, the investigators will directly measure procedural fidelity across all conditions to ensure the integrity of the procedures. Conforming with generally accepted practices in SCD, the investigators will use direct observation instruments reflective of the individual study protocols and evaluate for errors of omission and commission across at least 30% of all sessions, evenly distributed across study conditions and phases, for all participants and all implementers. These instruments typically consist of task analyses that specify what implementers should do (e.g., provide response-independent access to the reinforcer every 30 s), and what they should avoid (e.g., no vocal response from the therapist if SIB occurs). Investigators will then compute a measure of fidelity related (e.g., conditional probabilities of correct procedures and incorrect therapist behavior) to these two forms of errors relative to the planned steps and components for those conditions. Fidelity data will largely be collected in vivo, though recordings can be accessed if necessary (sometimes therapists and clients move out of frame of the camera so the investigators do not want to rely on video for fidelity data collection). To assist with procedural uniformity, May Institute will train implementers across sites and meet weekly with observers to review fidelity of implementation data and provide additional training. Adjustments to training procedures will be made or training boosters will be conducted if procedural fidelity drops below 90% for three consecutive implementations of any given procedure.
IOA: Mulitple data collectors will be responsible for in vivo data collection over the course of the study. To ensure that observation records reliably reflect what occurred during sessions, IOA will be tracked across all phases and conditions. Specifically, a second, naive, observer will collect data for IOA across all conditions using the same instrument as the primary data collector. Aligning with the generally accepted standards in SCD, these data will be gathered across at least 30% of sessions in each condition for each participant. The investigators will compare data between the observers to compute a measure of IOA. Data collectors will undergo a review of definitions and practice if IOA scores fall below 90% for three consecutive observations.
Specific Aim 5: Post hoc evaluation of subtype/intervention match. Following the conclusion of the study for each participant, the subtype of their SIB, the prescribed intervention, and the intervention outcome will be denoted. This process will allow for additional data sets related to subtype prevalence and subtype by intervention outcome to be collected. Individuals who exhibit SIB that fits Subtype 3 (i.e., SIB with self-restraint) will be reviewed on a case-by-case basis. If their self-restraint eliminates the occurrence of SIB, they will not be included in the study as SIB will not occur during the assessment phase.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Single case research design
| Arm | Type | Receives |
|---|---|---|
| Study 1: Longevity | Experimental | Behavioral: AUTOSIB across timeStudy 1: Longevity will evaluate the impact of matched and unmatched competing stimuli on reinforcement-based interventions as implementation durations are increased. Three conditions will be compared, using within-subjects single case designs: (a) baseline (no intervention), (b) intervention with competing stimuli matched to the hypothesized sensory consequences of SIB, and (c) intervention with competing stimuli unmatched to the hypothesized sensory consequences of SIB. Participants' specific intervention will be either noncontingent reinforcement (NCR) or differential reinforcement of other behavior (DRO), based on the outcomes of the pre-intervention assessments. During NCR, participants will receive access to competing stimuli on an ongoing and response-independent basis. During DRO, participants will receive access to competing stimuli contingent on the omission of SIB for a pre-determined length of time. Implementation will gradually increase up to a maximum of three hours. |
| Study 2: Schedule Thinning | Experimental | Behavioral: AUTOSIB diminished reinforcementStudy 2: Schedule Thinning will evaluate the impact of matched and unmatched competing stimuli on reinforcement-based interventions as access to reinforcers decreases. Three conditions will be compared, using within-subjects single case designs: (a) baseline (no intervention), (b) intervention with competing stimuli matched to the hypothesized sensory consequences of SIB, and (c) intervention with competing stimuli unmatched to the hypothesized sensory consequences of SIB. Participants' specific intervention will be either noncontingent reinforcement (NCR) or differential reinforcement of other behavior (DRO), based on the outcomes of the pre-intervention assessments. During NCR, participants will receive access to competing stimuli on an ongoing and response-independent basis. During DRO, participants will receive access to competing stimuli contingent on the omission of SIB for a pre-determined length of time. Access to reinforcers will decrease across successful implementations. |
Who may qualify
- Ages
- 2 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (4 listed)
- 2 years and older
- Diagnosis of intellectual and/or developmental disability
- Referred for assessment and treatment of self-injurious behavior
- Behavior maintained by automatic reinforcement function
Key exclusion criteria (1 listed)
- Behavior maintained by a social reinforcement (e.g., attention, escape) function
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AUTOSIB across timeIntervention will be in place across increasing time frames. | Behavioural | Study 1: Longevity |
| AUTOSIB diminished reinforcementIntervention will be in place with decreasing levels of reinforcement | Behavioural | Study 2: Schedule Thinning |
Primary outcome
Rate of Self-Injurious Behavior exhibited by individual participants as measured by direct observation
Time frame: Change in level of SIB from pre-intervention to intervention
Behavior that causes or has potential to cause injury to the participant
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Dec 2024.
- Individual participant dataSharing planned: Yes. The investigators will upload data to NIMH's National Database for Autism Research (NDAR). This process begins within six months of the award by creating a list of all data expected to be collected in the project using the Data Expected feature in NDAR, completing the NIMH Data Archive Data Submission Agreement form, and providing all necessary materials for any structures not yet defined in the NDA Data Dictionary. Within three months of receiving this information, NDAR contacts the study team to refine the plan for uploading the data. Item-level data for individual subjects are entered into NDAR for all study measures. Researchers are expected to associate the data deposited in NDA with their publications/findings - both positive and negative - using the NDA Study feature so that other researchers can locate the data. NDAR also allows researchers to search for data by study name.
Related trials for Self-Injurious Behavior
Recruiting
The Impact of a Nursing Care Program Based on Human Caring Theory on Adolescents With Self-harm
Self Harm
RecruitingObservational study
Evaluation of National Highly Specialized Care for Children and Adolescents With Severe Self-Harm or Eating Disorders
Self-harm Behavior, Eating Disorders
Not yet recruiting
Reducing Stigma - A Treatment for Early Psychosis to Prevent Suicide
Suicide, Mental Health Stigma
Active, not recruiting
Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide
Suicide, Attempted, Suicidal Ideation
Recruiting
Efficacy of Triple-daily 15mA tACS on Adolescent NSSI
Non-suicidal Self-injury (NSSI)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Joel E Ringdahl, PhD principal investigator
University of Georgia
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing AUTOSIB across time and AUTOSIB diminished reinforcement in people with Self-Injurious Behavior and Problem Behavior, run by University of Georgia at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rate of Self-Injurious Behavior exhibited by individual participants as measured by direct observation (time frame: Change in level of SIB from pre-intervention to intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Dec 2024.